In this survey respondents were asked about their routine approach to assessment and management of patients with non-thymomatous myasthenia gravis (MG).� The majority of respondents surgically manage myasthenia gravis.� Two-thirds of them perform this operation via a full or partial sternotomy.� About 20% of surgeons use VATS approaches, and transcervical and robotic approaches each were used by 5%.
Almost 85% of respondents consider the diagnosis of myasthenia gravis or MG with more than ocular symptoms to be sufficient indications for surgery.� A minority of surgeons, just over 15%, indicated that patients needed to have generalized symptoms before they would consider recommending thymectomy.� The most common surgical goal, favored by two-thirds of respondents, was complete thymectomy, whereas one-third believe that an extended or radical thymectomy is appropriate for management of MG.
Advanced age does not appear to be a contraindication to thymectomy for MG, even though some reports in the literature suggest that outcomes with regards to resolution of MG symptoms are not as favorable in older patients.� Preoperative preparation appears to include 2 or more different techniques for most surgeons.
Almost all surgeons obtain a CT scan as part of the preoperative evaluation.� Only 40% measure lung function, and just over 50% assess acetylcholine receptor antibody status.� MRI is not favored as a method of preoperative evaluation in these patients.� Interestingly, if a small encapsulated nodule consistent with a thymoma is discovered during a minimally invasive thymectomy, two-thirds of respondents would complete the thymectomy using a minimally invasive approach.
This was the first survey in this portal to attract relatively equal numbers of respondents from North America, Europe, and Asia, and there was a larger number than usual of respondents from Africa as well.
| 1. Do you perform thymectomy for myasthenia gravis? | |||
|---|---|---|---|
| answered question | 113 | ||
|
|
skipped question |
0
|
|
| Response Percent |
Response Count |
||
| Yes | 98.2% | 111 | |
| No, that disease is not treated surgically in my center | 0.0% | 0 | |
| No, that disease is treated surgically by other surgeons in my center | 1.8% | 2 | |
| 2. What is your standard surgical approach to non-thymomatous myasthenia gravis? | |||
|---|---|---|---|
| answered question | 113 | ||
|
|
skipped question |
0
|
|
| Response Percent |
Response Count |
||
| Partial sternotomy | 17.7% | 20 | |
| Full sternotomy | 50.4% | 57 | |
| Transcervical | 5.3% | 6 | |
| Thoracoscopic, bilateral | 4.4% | 5 | |
| Thoracoscopic, unilateral | 16.8% | 19 | |
| Robotic assisted of any type | 5.3% | 6 | |
| 3. What is your intent when performing thymectomy for MG? | |||
|---|---|---|---|
| answered question | 113 | ||
|
|
skipped question |
0
|
|
| Response Percent |
Response Count |
||
| Complete thymectomy | 63.7% | 72 | |
| Extended or radical thymectomy | 36.3% | 41 | |
| Other | 0.0% | 0 | |
| 4. What are your indications for surgery for MG? | |||
|---|---|---|---|
| answered question | 112 | ||
|
|
skipped question |
1
|
|
| Response Percent |
Response Count |
||
| Any patient diagnosed with MG is a candidate | 49.1% | 55 | |
| Disease beyond ocular involvement | 34.8% | 39 | |
| Severe generalized disease | 16.1% | 18 | |
| 5. Is older age a contraindication to thymectomy for myasthenia gravis? | |||
|---|---|---|---|
| answered question | 113 | ||
|
|
skipped question |
0
|
|
| Response Percent |
Response Count |
||
| Definitely | 2.7% | 3 | |
| Maybe | 30.1% | 34 | |
| Probably not | 35.4% | 40 | |
| No | 31.9% | 36 | |
| 6. What adjuncts do you or your medical colleagues use to prepare MG patients for surgery (check all that apply)? | |||
|---|---|---|---|
| answered question | 110 | ||
|
|
skipped question |
3
|
|
| Response Percent |
Response Count |
||
| Plasmapheresis | 65.5% | 72 | |
| Steroids | 70.9% | 78 | |
| Other pharmacologic immunosuppression | 30.9% | 34 | |
| Intravenous IgG | 48.2% | 53 | |
| 7. What evaluations are routine prior to thymectomy for MG (check all that apply)? | |||
|---|---|---|---|
| answered question | 112 | ||
|
|
skipped question |
1
|
|
| Response Percent |
Response Count |
||
| CT | 97.3% | 109 | |
| PFTs | 39.3% | 44 | |
| MRI | 8.0% | 9 | |
| Acetylcholine receptor antibody measurement | 53.6% | 60 | |
| 8. If a 1.5 cm encapsulated nodule suspicious for thymoma is discovered intraoperatively during a minimally invasive or transcervical thymectomy, how do you manage this? | |||
|---|---|---|---|
| answered question | 109 | ||
|
|
skipped question |
4
|
|
| Response Percent |
Response Count |
||
| Convert to an open operation | 23.9% | 26 | |
| Continue with a minimally invasive approach as planned | 65.1% | 71 | |
| Other | 11.0% | 12 | |
| 9. In what region do you practice? | |||
|---|---|---|---|
| answered question | 113 | ||
|
|
skipped question |
0
|
|
| Response Percent |
Response Count |
||
| North America | 31.9% | 36 | |
| Europe | 23.0% | 26 | |
| Asia | 25.7% | 29 | |
| Africa | 5.3% | 6 | |
| Central or South America | 13.3% | 15 | |
| Australia/New Zealand | 0.9% | 1 | |
©2012 CTSNet